Disc Medicine Statistics Share Statistics Disc Medicine has 34.77M
shares outstanding. The number of shares has increased by 16.51%
in one year.
Shares Outstanding 34.77M Shares Change (YoY) 16.51% Shares Change (QoQ) 0.19% Owned by Institutions (%) 91.07% Shares Floating 22.96M Failed to Deliver (FTD) Shares 91 FTD / Avg. Volume 0.03%
Short Selling Information The latest short interest is 2.43M, so 7% of the outstanding
shares have been sold short.
Short Interest 2.43M Short % of Shares Out 7% Short % of Float 7.8% Short Ratio (days to cover) 6.51
Valuation Ratios The PE ratio is -16 and the forward
PE ratio is -9.14.
Disc Medicine's PEG ratio is
-1.01.
PE Ratio -16 Forward PE -9.14 PS Ratio 0 Forward PS 64.3 PB Ratio 3.95 P/FCF Ratio -18.53 PEG Ratio -1.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Disc Medicine.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 21.17,
with a Debt / Equity ratio of 0.07.
Current Ratio 21.17 Quick Ratio 21.17 Debt / Equity 0.07 Debt / EBITDA -0.28 Debt / FCF -0.32 Interest Coverage -226.78
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.16M Employee Count 94 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 355K Effective Tax Rate -0.33%
Stock Price Statistics The stock price has increased by 24.9% in the
last 52 weeks. The beta is 2.5, so Disc Medicine's
price volatility has been higher than the market average.
Beta 2.5 52-Week Price Change 24.9% 50-Day Moving Average 58.93 200-Day Moving Average 54.91 Relative Strength Index (RSI) 52.57 Average Volume (20 Days) 360,708
Income Statement
Revenue n/a Gross Profit -156K Operating Income -129.72M Net Income -109.36M EBITDA -108.27M EBIT -108.43M Earnings Per Share (EPS) -3.96
Full Income Statement Balance Sheet The company has 192.43M in cash and 30M in
debt, giving a net cash position of 162.43M.
Cash & Cash Equivalents 192.43M Total Debt 30M Net Cash 162.43M Retained Earnings -298M Total Assets 665.06M Working Capital 640.99M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -93.93M
and capital expenditures -505K, giving a free cash flow of -94.43M.
Operating Cash Flow -93.93M Capital Expenditures -505K Free Cash Flow -94.43M FCF Per Share -3.42
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields IRON does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for IRON is $90,
which is 49.3% higher than the current price. The consensus rating is "Buy".
Price Target $90 Price Target Difference 49.3% Analyst Consensus Buy Analyst Count 9
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 30, 2022. It was a
backward
split with a ratio of 1:10.
Last Split Date Dec 30, 2022 Split Type backward Split Ratio 1:10
Scores Altman Z-Score 24.53 Piotroski F-Score 2
